News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ichor Medical Systems, Inc. Melanoma Vaccine Clinical Trial Moves to Highest Dose Level



3/4/2008 11:55:46 AM

SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, whose advanced TriGrid electroporation system is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today that recruitment of patients has commenced for the final and highest dose level for their Phase I melanoma vaccine clinical trial in the study being conducted by Memorial Sloan-Kettering Cancer Center.

Read at BioSpace.com


comments powered by Disqus
   
Melanoma
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES